Profound Medical (PROF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Vaxart ( NASDAQ:VXRT ) Third Quarter 2022 Results Key Financial Results Net loss: US$29.3m (loss widened by 67% from 3Q...
VAXART, INC. (VXRT) delivered earnings and revenue surprises of 4.17% and 100%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?